[Non-surgical treatment for pancreatic cancer]

Nihon Shokakibyo Gakkai Zasshi. 2006 Apr;103(4):391-7.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bevacizumab
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Cisplatin / administration & dosage
  • Clinical Trials, Phase III as Topic
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Drug Combinations
  • Gemcitabine
  • Humans
  • Irinotecan
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin
  • Oxonic Acid / administration & dosage
  • Pancreatic Neoplasms / drug therapy*
  • Pyridines / administration & dosage
  • Randomized Controlled Trials as Topic
  • Tegafur / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • Organoplatinum Compounds
  • Pyridines
  • Oxaliplatin
  • Deoxycytidine
  • S 1 (combination)
  • Tegafur
  • Bevacizumab
  • Oxonic Acid
  • Irinotecan
  • Cisplatin
  • Camptothecin
  • Gemcitabine